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Background: Mycoplasma hyopneumoniae is the causative agent of porcine enzootic pneumonia (EP), a mild,
chronic pneumonia of swine. Despite presenting with low direct mortality, EP is responsible for major economic
losses in the pig industry. To identify the virulence-associated determinants of M. hyopneumoniae, we determined
the whole genome sequence of M. hyopneumoniae strain 168 and its attenuated high-passage strain 168-L and
carried out comparative genomic analyses.
Results: We performed the first comprehensive analysis of M. hyopneumoniae strain 168 and its attenuated strain
and made a preliminary survey of coding sequences (CDSs) that may be related to virulence. The 168-L genome
has a highly similar gene content and order to that of 168, but is 4,483 bp smaller because there are 60 insertions
and 43 deletions in 168-L. Besides these indels, 227 single nucleotide variations (SNVs) were identified. We further
investigated the variants that affected CDSs, and compared them to reported virulence determinants. Notably,
almost all of the reported virulence determinants are included in these variants affected CDSs. In addition to
variations previously described in mycoplasma adhesins (P97, P102, P146, P159, P216, and LppT), cell envelope
proteins (P95), cell surface antigens (P36), secreted proteins and chaperone protein (DnaK), mutations in genes
related to metabolism and growth may also contribute to the attenuated virulence in 168-L. Furthermore, many
mutations were located in the previously described repeat motif, which may be of primary importance for
virulence.
Conclusions: We studied the virulence attenuation mechanism of M. hyopneumoniae by comparative genomic
analysis of virulent strain 168 and its attenuated high-passage strain 168-L. Our findings provide a preliminary
survey of CDSs that may be related to virulence. While these include reported virulence-related genes, other novel
virulence determinants were also detected. This new information will form the foundation of future investigations
into the pathogenesis of M. hyopneumoniae and facilitate the design of new vaccines.
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Mycoplasma hyopneumoniae causes porcine enzootic
pneumonia, which is a mild, chronic pneumonia of swine
[1]. This highly infectious organism has a worldwide
distribution. The primary mycoplasmal infection often
becomes complicated by secondary bacterial and viral
infections [2], resulting in more severe lung lesions and
production losses. Relative control has been achieved
through active vaccination programs, but porcine enzootic
pneumonia continues to be a major economic problem in
the swine industry. While progress has been made in
understanding the molecular basis of some Mycoplasma
diseases [3], advances in M. hyopneumoniae research have
been hampered by its fastidious growth condition and the
lack of genetic tools and transformation protocols. To
date, few virulence determinants or virulence-associated
determinants have been identified. Attachment to the re-
spiratory epithelium is a prerequisite for host colonization
and is mediated by the membrane protein P97 [4]. This
protein is located on the outer membrane surface, and its
role in adherence has been firmly established. The general
region of P97 that mediates adherence to swine cilia is
thought to be the R1 region, near the C-terminus of the
protein [5]. To bind cilia, a minimum of eight tandem
copies of the pentapeptide sequence (AAKPV/E) in R1 are
required [5]. Although the function of R2 in vivo is un-
known, both it and R1 are required to bind heparin [6].
The P97 genes of M. hyopneumoniae strains 7448, 232,
and J code for proteins with 10, 15, and 9 of the previously
described R1 repeating units (AAKPV/E), respectively; all
three strains had more than the minimum number of tan-
dem copies (8 tandem copies) required for cilium binding
[7]. Moreover, monoclonal antibodies F1B6 and F2G5,
which both react predominantly with P97 [4,5], only
partially block adherence of M. hyopneumoniae to recep-
tors on epithelial cell cilia [8]. These observations indicate
that molecules other than P97 play a role in facilitating
adherence of M. hyopneumoniae to swine cilia. Compara-
tive transcriptomic and proteomic studies are also per-
formed to study transcriptional changes that occur during
disease and investigate differentially expressed proteins
in pathogenic and non-pathogenic strains [9-11]. Several
M. hyopneumoniae proteins, including immunodominant
proteins (P36 [12], P46 [13], and P65 [14]), adhesin-
related proteins (P102 [15], P146 [16], P159 [17], P216
[18], and LppT [16]), and a 54-kDa cytotoxic factor [19],
have been characterized; however, the biological functions
of these proteins in pathogenesis are not well understood.
Comparative genomic analysis has previously revealed
mechanisms of M. hyopneumoniae pathogenicity [7] and
predicted unidentified virulence factors, including genes
involved in secretion and/or traffic between host and
pathogen cells, or with evasion and/or modulation of the
host immune system [20,21]. In 2005, Vasconcelos et al.sequenced a pathogenic and a non-pathogenic strain of
M. hyopneumoniae and performed a comparative gen-
omics approach to identify putative virulence genes [7].
They identified various CDSs that could be considered
candidate virulence genes, including cilium adhesin
homologs, lipoproteins, and other components which
might contribute to virulence [7]. However, comparative
genomic analysis of a virulent M. hyopneumoniae strain
versus its attenuated strain is lacking.
The need to control the spread of M. hyopneumoniae
prompted the development of live attenuated vaccine
strains. M. hyopneumoniae strain 168-L has been exten-
sively used as vaccine against M. hyopneumoniae in
China [22,23]. This attenuated vaccine strain is derived
from the virulent parent strain 168. Strain 168 was origin-
ally isolated in 1974, from an Er-hua-nian pig (a Chinese
local breed very sensitive to M. hyopneumoniae) with typ-
ical clinical and pathogenic characteristics of mycoplasmal
pneumonia of swine (MPS) [24]. This field strain was
gradually attenuated by more than 300 continuous pas-
sages through KM2 cell-free medium (a modified Friis
medium) and the 380th passage was named strain 168-L.
Currently, the genetic basis for the attenuation of viru-
lence in 168-L is poorly understood.
To gain new insight into the components that con-
tribute to virulence and the mechanisms by which M.
hyopneumoniae causes disease, we sequenced the gen-
omes of strains 168 and 168-L. This allowed us to per-
form the first comprehensive analysis of virulent and
attenuated strains, and identify CDSs that may be related
to virulence. We further investigated these putative viru-
lence related CDSs and compared them with reported
virulence determinants. Notably, almost all reported
virulence determinants were found in putative virulence
related CDSs. Besides the reported virulence determi-
nants, other candidate virulence genes were also identi-
fied. The study of these candidate virulence genes and
their corresponding products will be important to better
comprehend the pathogenesis of M. hyopneumoniae.
Results and discussion
Genomic features of M. hyopneumoniae 168-L and its
global comparison with pathogenic strain 168
The complete genome of M. hyopneumoniae 168-L con-
sists of a 921,093 bp (GC content 28.46%) single circular
chromosome (GenBank accession number CP003131). A
total of 689 protein-encoding genes were predicted. The
average protein size is 378 amino acids and the mean
coding percentage is 84.8%. Approximately 51% of genes
were assigned to specific functional clusters of ortholo-
gous groups (COGs), and 28% were assigned an enzyme
classification (EC) number (Figure 1). Comparison with
the M. hyopneumoniae 168 genome (GenBank accession
CP002274) revealed a highly conserved gene content
Figure 1 Genome architecture. The dnaA gene is at position zero. Moving inside, the first circle shows the genome length (units in M.
hyopneumoniae); the second and the third circles show the locations of the predicted CDSs on the plus and minus strands, respectively, which
were color-coded by COG categories (the color codes for the functional assignments are shown in the key); the fourth circle shows tRNAs
(purple) and rRNAs (red); the fifth circle shows the centered GC (G+C) content of each CDS (blue: above mean and cyan: below mean); and the
sixth circle shows the GC (G+C) skew plot (red: above zero and pink: below zero). Circles 7–10 show comparative amino acids analysis of 168
with amino acids identities color-coded according to the similarity shown in the key to strains 168-L (seventh circle), 232 (eight circle), J (ninth
circle), 7448 (tenth circle).
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4,483 bp smaller than that of 168 (925,576 bp), because
there are 60 insertions and 43 deletions (indels; inser-
tions and deletions of any size) in 168-L relative to 168
(see Additional file 1: Table S1; Additional file 2: Table
S2; Additional file 3: Table S3). Among these, 33 indels
are located in predicted CDSs, and 70 are in noncoding
regions. Besides these indels, 227 single nucleotide varia-
tions (SNVs) were identified between 168 and 168-L
(Additional file 4: Table S4). While 31 SNVs were mapped
to intergenic regions, 196 were in coding regions, indu-
cing amino acid substitutions, frame shifts, and transla-
tional stops.
ISMHp1-Related genetic variations between 168 and 168-L
The difference between the genome sizes of strains 168
and 168-L is mainly due to differences in the duplication
of Insertion Sequence (IS) elements. IS elements are dis-
tributed stochastically across the entire genome of both
strains. The 168-L genome contains nine complete and
one disrupted IS elements, which is almost identical to
that of 168 except for slight differences in ISMHp1.There are nine complete copies of ISMHp1 in 168-L,
but 12 copies in 168. The difference in ISMHp1 copy
number between 168 and 168-L is due to three complete
ISMHp1 deletions (located 690 kb, 870 kb, and 900 kb
from oriC) and one complete ISMHp1 inversion, which
was originally located at 378 kb from oriC, but was
inverted in 168-L (1656 bp, located 372 kb from oriC)
(Figure 2a).
Other than the IS elements, notable large-scale genomic
differences were also indicated. Compared to strain 168, a
genomic deletion of approximately 1.36 kb (locus 1: be-
tween MHP168L_311 and MHP168L_729) was identified,
which had been substituted with an approximately 2.32 kb
novel insertion sequence (locus 2) that was joined to a
complete ISMHp1 element in 168-L (Figure 2b). This
168-L-related insertion fragment was also observed in
strains 7448 and 232.
Molecular analysis of integrative conjugative element (ICE)
The integrative conjugative element (ICE) is a mobile
DNA that is probably involved in genomic recombination
events and in pathogenicity. The ICEH elements are more
Figure 2 Alignment of the whole genomes and inverted regions. (a) Alignment of the M. hyopneumoniae 168 and 168-L genomes.
(b) Alignment of the inverted regions of 168 relative to 168-L. The gray bars represent the forward and reverse strands. Green triangles represent
ISMHP1 elements. DNA BLASTN alignments (BLASTN matches) between the two sequences are indicated by a red (same strand) or blue
(opposite strand) line.
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locus inM. hyopneunomiae [25], suggesting an accelerated
evolution of these constins [26]. During a survey of spe-
cific sequences, a specific 26.9-kb region with similarity to
the integrative conjugal element of M. fermentans (ICEF)
[27] was found in strain 168, which was designated ICEH
(for integrative conjugal element of M. hyopneumoniae).
Unlike ICEH in strains 7448 and 232, which consist of
nineteen and twenty two CDSs, respectively, the ICEH168
consist of 20 CDSs (Additional file 5: Table S5). The
organization of these elements is very similar. Some CDSs
present similarity to tra genes, which are usually asso-
ciated with the bacteria conjugative plasmids such as traK,
traI, traE [26]. The ICEH168 has three tra genes, with one
traG and two copies of the traE gene. Besides, a CDS
encoding for a single strand binding protein (SSB) that is
essential for the transfer process is also observed.
The ICE analysis of three M. hyopneumoniae genomes
(7448, J and 232) carried out previously, revealed that
the ICEH is present in the two pathogenic strains (7448
and 232) but is absent from the non-pathogenic one
(J strain) [26]. Interest has therefore shifted to questions
of whether the ICEH is present in the attenuated vaccinestrain 168-L. Interestingly, the ICEH was also observed in
strain 168-L. Moreover, the ICEH168 and ICEH168-L are
almost the same, except for a missense mutation (G192E)
identified in ICEH-ORF3 (MHP168_235). Our analyses in-
dicate that the ICEH may not only present in pathogenic
strains of M. hyopneumoniae.
Mutations affecting epithelium adhesion
In our previous study, the ability of adherence and dam-
age to the cilia between strains 168 and 168-L were
compared by using scanning electron microscopy. The
results showed that the pathogenic strain 168 adheres to
cilia inducing tangling, clumping, and longitudinal split-
ting of cilia, while the strain 168-L does not cause ciliary
damage comparing to control group [28]. The adherence
of M. hyopneumoniae to porcine ciliated respiratory cells
is essential for the organism to colonize the respiratory
epithelium and cause pneumonia [4]. The adherence
process is mainly mediated by receptor-ligand interac-
tions, and the M. hyopneumoniae proteins possibly
involved in these interactions are obvious candidates as
virulence factors [8,29-31]. We investigated the genetic
variation between strains 168 and 168-L (Table 1;
Table 1 Complete list of "168-L-specific" genetic variations in CDSs
168-L gene 168-L gene product Variation 168 Locus Effect on 168-L coding
MHP168L_010 Putative uncharacterized protein SNV MHP168_010 L368A substitution
MHP168L_014 Fructose-bisphosphate aldolase Deletion+SNV MHP168_014 N-terminal deletion+SNV
MHP168L_020 ABC transporter ATP-binding protein Deletion MHP168_020 264-aa deletion
MHP168L_022 Putative uncharacterized protein SNV MHP168_022 S22S substitution
MHP168L_030 Topoisomerase IV subunit A SNV MHP168_030 K140E substitution
MHP168L_033 Predicted protein Deletion MHP168_033 N-terminal deletion
MHP168L_035 hypothetical protein SNV MHP168_035 K177R,A221T substitution
MHP168L_058 Glycyl-tRNA synthetase SNV MHP168_058 P226P substitution
MHP168L_064 hypothetical protein SNV MHP168_064 Y552H substitution
MHP168L_065 Predicted protein Deletion MHP168_065 Frameshift out 20aa
MHP168L_066 hypothetical protein Insertion+SNV MHP168_066 Frameshift out 42aa; F324S substitution
MHP168L_069 Chaperone protein dnaK SNV MHP168_069 P407P substitution
MHP168L_084 Amino acid permease SNV MHP168_084 R13K,T396A substitution
MHP168L_085 NADH oxidase Insertion+SNV MHP168_085 "TG" insertion; stop; 5aa truncation; E395G
substitution
MHP168L_086 Thymidine phosphorylase SNV MHP168_086 V15F substitution
MHP168L_103 Outer membrane protein-P95 SNV MHP168_103 Stop;149-aa truncation
MHP168L_105 ATP-dependent protease binding protein SNV MHP168_105 I159I substitution
MHP168L_110 Protein p97, cilium adhesin SNV MHP168_110 SNV in repeat region
MHP168L_114 50S ribosomal protein L2 SNV MHP168_114 A2A substitution
MHP168L_127 50S ribosomal protein L15 SNV MHP168_127 E95K substitution
MHP168L_142 Phosphopentomutase SNV MHP168_142 N8I substitution
MHP168L_152 ribulose-phosphate 3-epimerase Deletion+SNV MHP168_152 I211F substitution
MHP168L_167 L-lactate dehydrogenase SNV MHP168_167 N204D substitution
MHP168L_168 Hexosephosphate transport protein SNV MHP168_168 Q122S substitution
MHP168L_182 Putative uncharacterized protein Deletion MHP168_182 Frameshift;105-aa truncation
MHP168L_186 Pyruvate dehydrogenase E1-alpha subunit SNV MHP168_186 S194G substitution
MHP168L_187 Adenine phosphoribosyltransferase SNV MHP168_188 534-aa N-terminal extension
MHP168L_198 Protein P102 SNV MHP168_198 L677L substitution
MHP168L_209 ABC transporter ATP-binding protein SNV MHP168_209 K258E substitution
MHP168L_212 Oligopeptide transport system permease
protein
SNV MHP168_212 P203S substitution
MHP168L_235 Putative ICEF Integrative Conjugal Element-II SNV MHP168_235 G192E substitution
MHP168L_243 Serine hydroxymethyltransferase Insertion MHP168_243 No change
MHP168L_264 ISMHp1 transposase SNV MHP168_264 S232P,C229R substitution
MHP168L_275 lipoate-protein ligase A SNV MHP168_275 A179T substitution
MHP168L_284 Cobalt import ATP-binding protein cbiO 1 SNV MHP168_284 K64E substitution
MHP168L_289 Cation-transporting P-type ATPase SNV MHP168_289 E100D substitution
MHP168L_308 putative ABC transporter ATP-binding protein SNV MHP168_308 T708A,M700L substitution
MHP168L_311 Putative uncharacterized protein SNV MHP168_311 D266E substitution
MHP168L_312 Putative uncharacterized protein Insertion+SNV MHP168_312 Insertion;R49R,I247L substitution
MHP168L_314 Putative uncharacterized protein Insertion+deletion MHP168_314 Stop;14-aa truncation
MHP168L_322 hypothetical protein Insertion MHP168_322 Frameshift;5-aa truncation
MHP168L_345 Predicted protein Deletion MHP168_345 Frameshift;53-aa truncation
MHP168L_355 Putative uncharacterized protein Insertion MHP168_355 21-aa N-terminal deletion
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Table 1 Complete list of "168-L-specific" genetic variations in CDSs (Continued)
MHP168L_361 hypothetical protein SNV MHP168_361 L265L substitution
MHP168L_377 Putative uncharacterized protein SNV MHP168_377 E407K substitution
MHP168L_378 P60-like lipoprotein SNV MHP168_378 S143N substitution
MHP168L_379 HIT-like protein SNV MHP168_379 D58N substitution
MHP168L_381 hypothetical protein Insertion MHP168_381 Frameshift
MHP168L_386 P37-like ABC transporter substrate-binding
lipoprotein
Insertion MHP168_386 Frameshift out 84aa
MHP168L_389 Putative membrane lipoprotein SNV MHP168_389 A265S substitution
MHP168L_392 lipoprotein SNV MHP168_392 T6M substitution
MHP168L_394 ABC transporter permease protein SNV MHP168_394 A492G substitution
MHP168L_400 Ribonuclease III SNV MHP168_400 V58I substitution
MHP168L_401 Putative uncharacterized protein Deletion MHP168_401 Frameshift out 133aa
MHP168L_409 Putative type III restriction-modification system:
methylase
Deletion MHP168_409 Frameshift out 171aa
MHP168L_412 ISMHp1 transposase SNV MHP168_412 G50V substitution
MHP168L_413 ABC transporter ATP-binding protein SNV MHP168_413 D118Y substitution
MHP168L_423 Putative uncharacterized protein SNV MHP168_423 Y18S substitution
MHP168L_424 Lppt protein SNV MHP168_424 L814F substitution
MHP168L_434 hypothetical protein SNV MHP168_434 W107C substitution
MHP168L_444 Putative uncharacterized protein SNV MHP168_444 V123A substitution
MHP168L_445 Putative uncharacterized protein Deletion MHP168_445 3-aa deletion in repeat region
MHP168L_454 Putative uncharacterized protein Insertion+SNV MHP168_454 L423I substitution
MHP168L_455 Predicted protein Deletion+SNV MHP168_455 59-aa extension;P51P substitution
MHP168L_456 Putative uncharacterized protein SNV MHP168_456 substitution
MHP168L_457 Putative uncharacterized protein Insertion+deletion
+SNV
MHP168_457 Frameshift;substitution
MHP168L_462 ABC transporter ATP-binding protein SNV MHP168_462 V219L substitution
MHP168L_463 ABC transporter permease protein SNV MHP168_463 Amino acid substitution
MHP168L_473 hypothetical protein Insertion MHP168_473 Frameshift out 84aa
MHP168L_482 Phosphoenolpyruvate protein
phosphotransferase
SNV MHP168_482 E562G substitution
MHP168L_490 hypothetical protein Insertion MHP168_490 Stop;114-aa truncation
MHP168L_498 Putative uncharacterized protein SNV MHP168_498 D137E substitution
MHP168L_503 P216 surface protein Insertion MHP168_503 Q repeat insertion
MHP168L_504 P159 membrane protein SNV MHP168_504 G403D,L375S, G240A substitution
MHP168L_505 YX1 SNV MHP168_505 V175I substitution
MHP168L_506 Putative uncharacterized protein SNV MHP168_506 N16N substitution
MHP168L_507 asparagine synthetase A SNV MHP168_507 I85M substitution
MHP168L_510 Oligopeptide transport system permease
protein
SNV MHP168_510 S19S substitution
MHP168L_523 Xylose ABC transporter ATP-binding protein SNV MHP168_523 S8S substitution
MHP168L_531 Putative uncharacterized protein Deletion+SNV MHP168_531 Amino acid substitution
MHP168L_541 Predicted protein SNV MHP168_541 L50L substitution
MHP168L_557 Potassium uptake protein SNV MHP168_557 D69Y substitution
MHP168L_558 Potassium uptake protein SNV MHP168_558 H425Y,N477D substitution
MHP168L_559 hypothetical protein SNV MHP168_559 D1236G substitution
MHP168L_567 hypothetical protein SNV MHP168_567 D68N substitution
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Table 1 Complete list of "168-L-specific" genetic variations in CDSs (Continued)
MHP168L_571 hypothetical protein Insertion+deletion
+SNV
MHP168_571 Frameshift;amino acid substitution
MHP168L_573 Putative uncharacterized protein Deletion+SNV MHP168_573 Amino acid substitution;N-terminal extension
MHP168L_576 ISMHp1 transposase SNV MHP168_576 Amino acid substitution
MHP168L_589 Membrane nuclease, lipoprotein SNV MHP168_589 S98S substitution
MHP168L_596 Glycerol-3-phosphate dehydrogenase SNV MHP168_596 L155V substitution
MHP168L_600 ABC transporter ATP binding protein SNV MHP168_600 P1014L,P1037L substitution
MHP168L_606 hypothetical protein Deletion+SNV Frameshift;amino acid substitution
MHP168L_614 ABC transporter xylose-binding lipoprotein SNV MHP168_614 I51V substitution
MHP168L_621 hypothetical protein SNV MHP168_621 G87G substitution
MHP168L_631 ABC transporter ATP-binding-Pr1 SNV MHP168_631 R60W substitution
MHP168L_638 Putative uncharacterized protein Insertion+SNV MHP168_638 K insertion in K repeat region;K7K substitution
MHP168L_639 5'-nucleotidase precursor SNV MHP168_639 E411K substitution
MHP168L_666 Ribosomal RNA small subunit
methyltransferase G
Deletion MHP168_666 Frameshift out 12aa
MHP168L_668 Prolipoprotein p65 SNV MHP168_668 T138A substitution
MHP168L_671 XAA-PRO aminopeptidase SNV MHP168_671 G321G substitution
MHP168L_672 Putative uncharacterized protein SNV MHP168_672 E104E substitution
MHP168L_673 Putative uncharacterized protein SNV MHP168_673 I52K,E127K substitution
MHP168L_675 hypothetical protein SNV MHP168_675 Y175D substitution
MHP168L_676 P146 adhesin like-protein, p97 paralog Insertion+SNV MHP168_676 Q insertion in PQ repeat region;S404S,W404R
substitution
MHP168L_688 Putative uncharacterized protein SNV MHP168_688 K48N substitution
MHP168L_698 hypothetical protein SNV MHP168_698 R126G,V159G substitution
MHP168L_707 hypothetical protein Insertion MHP168_707 "F" insertion
MHP168L_747 hypothetical protein Insertion+deletion
+SNV
MHP168_091 N repeat insertion;39-aa N-terminal extension;
SNV
MHP168L_748 Protein P102 Deletion+SNV MHP168_108 Stop;782-aa truncation;SNV
MHP168L_749 Putative type III restriction-modification system:
methylase
Deletion MHP168_730 N-terminal deletion
MHP168L_750 hypothetical protein Deletion MHP168_435 Frameshift
MHP168L_r002 16S ribosomal RNA SNV MHP168_r002 Amino acid substitution
MHP168L_t027 tRNA-Ser SNV MHP168_t027 Amino acid substitution
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affecting CDSs corresponding to previously described
mycoplasma adhesins (P97, P102, P146, P159, P216,
MgPa, LppS, and LppT) [7]. Notably, almost all the
reported mycoplasma adhesins are included in the CDSs
affected by mutations (Table 1).
In 168-L, three transversions were identified in the R1
region, near the C-terminus, of P97 (MHP168_110/
MHP168L_110), which encodes cilium adhesin. In M.
hyopneumoniae, attachment to the respiratory epithe-
lium is mainly mediated by the membrane protein P97
[4]. This protein is located on the outer membrane sur-
face, and its role in adherence has been firmly estab-
lished. To bind cilia, a minimum of eight tandem copies
of the pentapeptide sequence (AAKPV/E) in R1 arerequired [5]. Notably, all three transversion mutations
were located in the tandem repeat unit (AAKPV/E),
causing an E863V substitution. Significant alteration in
this critical repeat unit might partly affect the adhesion
reaction in 168-L.
Previous studies have demonstrated that P102 binds
fibronectin and contributes to the recruitment of plas-
min(ogen) to the M. hyopneumoniae cell surface [15].
P102 is commonly linked to P97 cilium adhesin, forming
a two-gene operon [32]. Both P97 and P102 have several
paralogs within the M. hyopneumoniae genome. How-
ever, the paralogs have only part of the complete se-
quence. Interestingly, P102, the companion gene in this
operon, was truncated at 564 bp by a single base inser-
tion in strain 168. Another intact copy of P102 (99%
Figure 3 Metabolic potential. The metabolic pathways of M. hyopneumoniae strains 168 and 168-L were mapped and analyzed using KEGG
Pathway Database. Those pathways, containing mutations affected metabolic-related genes, are shown in green.
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in strain 168-L, the original truncated P102 was reverted
to the intact one, while another intact copy of P102, 85
kb away, was truncated.
The P146 adhesin-like protein of M. hyopneumoniae
shows strong similarity to the LppS lipoprotein of
Mycoplasma conjunctivae, which is involved in in vitro ad-
hesion [16]. In addition, the N-terminus region of P146
also shows strong similarity to the P97 adhesin, and has a
strongly hydrophobic region (amino acids 7–29), indicat-
ing a transmembrane region, and suggesting that the
protein is expressed on the surface of M. hyopneumoniae
cells [33]. Compared with its counterpart MHP168_676 in
168, MHP168L_676 from 168-L has an in-frame insertion
of one amino acid (Q) at the N-terminus of P146. The
enormous intra-specific diversity shown for the P146 en-
coding gene is at least partly because of differences be-
tween several repeat regions present in the gene, most
notably a polyserine chain of variable length, and a [Q]n
[(P/S)Q]m repeat region [34]. Interestingly, this one in-
frame insertion (Q) was located in the [Q]n[(P/S)Q]m
repeat region. Polyserine chains often function as a spacer
region in proteins involved in complex carbohydrate deg-
radation [35], while sequences rich in both proline and
glutamine are not uncommon and can form a conform-
ation known as a polyproline II helix [36,37]. Suchproline-rich sequences are often involved in binding pro-
cesses and are highly immunogenic [37]. However, be-
cause the function of the P146 protein remains unknown,
correlations with virulence or adhesion are speculative
and need further investigation.
P159 is a proteolytically processed surface adhesin of
M. hyopneumoniae [17]. Three proteins with apparent
molecular masses of 27 (P27), 52 (P52), and 110 (P110)
kDa were identified through proteomic analysis of M.
hyopneumoniae lysates [17], with each representing a
different region spanning P159. These cleavage frag-
ments are located on the cell surface and present at all
growth stages. In 168-L, MHP168L_504 (P159) has a
missense mutation resulting in a G240A replacement in
the (S)(S)G(G)S repeat region of P159. Although this (S)
(S)G(G)S repeat region has been reported, its biological
function is unknown.
P216 (MHP168L_503/MHP168_503) is a proteolytic-
ally processed cilium and heparin binding protein of M.
hyopneumoniae [18]. This surface protein is post-
translationally processed to generate N-terminal P120
and C-terminal P85 fragments, both of which can bind
cilia [18]. The 168-L P216 gene has an in-frame four
amino acid deletion in a poly Q motif near the C-
terminus. Previous studies have suggested that poly Q
and KEKE motifs may play a role in maintaining P85 on
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tions affecting P216 may affect its cilium adhesion and
may be associated with virulence attenuation in 168-L.
The MHP168L_424 gene and its gene product LppT
were analyzed in detail because they showed approxi-
mately 22% identity to the LppT protein from M.
conjunctivae. LppT is the second gene in a two gene op-
eron with LppS, which was reported to be an adhesin in
M. conjunctivae [16]. The LppT gene lacked a promoter
and is likely to be co-transcribed with LppS, thus sug-
gesting a functional relationship between LppS and
LppT [16]. In M. hyopneumoniae, LppT encoded a pro-
tein of 954 aa with a calculated molecular mass 108 kDa.
The gene product encoded by LppT is also a membrane
protein, with a signal sequence of 34 aa at the amino-
terminal end and a transmembrane structure. Notably,
one of the amino acid substitutions in 168-L occurs near
the C-terminus of LppT, resulting in a L814F replacement.Mutations altering the cell envelope and genes encoding
secreted proteins
Cell envelope proteins and secreted proteins are involved
in virulence, host cell interaction, and immune responses
[14,38,39]. Outer membrane protein-P95 is a cell envelope
protein in M. hyopneumoniae. In 168-L, MHP168L_103
(P95) is truncated by a nonsense mutation compared to
168, resulting in an E965* termination near the C-
terminus of P95. Significant alteration in this outer mem-
brane protein could conceivably cause a truncation in
coding region, and in turn alter the function of P95 outer
membrane protein.
M. hyopneumoniae contains an abbreviated membrane
protein secretory system [1]. The pathway consists of secA
(MHP168L_088), secY (MHP168L_128), secD (MHP168L_
259), prsA (MHP168L_664), dnaK (MHP168L_069), trigger
factor (MHP168L_154), and lepA (MHP168L_076). It
has recently been demonstrated that some pathogenic
bacteria use a type IV secretion system, composed of
subunits related to the conjugation machinery, to de-
liver effector molecules to host cells [40], and that this
system may be involved in pathogenesis [41]. We found
no pathogenic mutations in the protein secretory
system, except a synonymous substitution (P407P) in
MHP168L_069, which encodes chaperone protein DnaK.Mutations affecting antigens
Studies on the antigenic properties of M. hyopneumoniae
revealed several immunodominant proteins, including the
P36 cytosolic protein [12,42], the P46, P65, and P74
membranous proteins [43-46], the elongation factor Tu
[47], the chaperone protein DnaK [47], the pyruvate de-
hydrogenase E1-beta subunit [47], and the P97 adhesin
[4]. The functions of these proteins have not been wellelucidated, but specific reactants may eventually be useful
tools to diagnose M. hyopneumoniae [48].
The cytosolic P36 protein is a lactate dehydrogenase
[49] that induced an early immune response in pigs
that are experimentally and naturally infected by M.
hyopneumoniae [50]. Comparative studies with other
Mycoplasmas commonly found in pigs demonstrated
that the P36 proteins carry highly conserved species-
specific antigenic determinants for M. hyopneumoniae
[42]. Hyperimmune sera produced against recombinant
P36 protein showed no reactivity against other porcine
Mycoplasmas, including M. flocculare, M. hyorhinis,
and Acholeplasma laidlawii [12]. Notably, one of the
observed amino acid substitutions in 168-L occurs near
the C-terminus of P36 (MHP168L_167), resulting in a
N204D replacement.
P65 is an immunodominant surface lipoprotein of M.
hyopneumoniae that is specifically recognized during dis-
ease [14]. Analysis of the translated amino acid sequence
of the gene encoding p65 revealed similarity to the
GDSL family of lipolytic enzymes [14]. The monospecific
antibodies against heat shock protein-like P42 antigen,
part of P65, can block the growth of M. hyopneumoniae
[51]. In 168-L, MHP168L_668 (P65) has a missense mu-
tation resulting in a T138A replacement.Mutations affecting transport proteins
As Mycoplasmas are dependent on the exogenous sup-
ply of many nutrients, it has been predicted that they
may need many transport systems [3]. Motif analysis
revealed a family of proteins with a phosphotransferase
(PTS) motif. The open reading frames (ORFs) included
sgaA (MHP168L_422), sgaB (MHP168L_421), sgaT (MHP
168L_563), mtlF (MHP168L_739), mtlA (MHP168L_561),
nagE (MHP168L_582), and licA (MHP168L_041) [7].
However, no mutations were identified in this PTS
transporter family. There are approximately 30 genes
with ABC transporter family signatures in the genome
of M. hyopneumoniae 168-L (Additional file 7: Table S7),
and five missense mutations and one synonymous substi-
tution were identified in this group. These included a co-
balt import ATP-binding protein (MHP168L_284, K64E),
an ABC transporter permease protein (MHP168L_394,
A492G), a xylose ABC transporter ATP-binding protein
(MHP168L_523, S8S), and three ABC transporter ATP-
binding proteins (MHP168L_413, D118Y; MHP168L_462,
V219L; MHP168L_631, R60W). Interestingly, the expres-
sion of MHP168L_394 and MHP168L_413 was reported
to be up-regulated in vivo during disease relative to
in vitro-grown [11]. The variability between strains 168
and 168-L in multi-transport proteins indicates that
they may affect growth and survival in different hosts or
host tissues.
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M. hyopneumoniae strain 168 encodes 695 genes, approxi-
mately one quarter of which are involved in metabolism
and in vivo growth. Of particular interest were the muta-
tions observed in the genes involved in various metabolic
pathways (Figure 3), including glycolysis/gluconeogenesis
(MHP168_167, MHP168_186), purine metabolism (MHP
168_289, MHP168_639), pyrimidine metabolism (MHP
168_086), glycerophospholipid metabolism (MHP168_596),
oxidative phosphorylation (MHP168_085), aminoacyl-
tRNA biosynthesis (MHP168_058), and the pentose phos-
phate pathway (MHP168_142, MHP168_152). An in-frame
insertion of two amino acids (TG), a missense mutation
(E393G) and a nonsense mutation (N456*) were identified
in 168-L near the C-terminus of MHP168L_085, which
encodes a NADH oxidase involved in oxidative phosphoryl-
ation. Mycoplasma genomes are deficient in genes coding
for components of intermediary and energy metabolism [3].
Thus, Mycoplasmas depend mostly on glycolysis to
synthesize ATP [3]. In the glycolysis pathway, missense
mutations in both L-lactate and pyruvate dehydrogenase
were observed, resulting in N204D and S194G replace-
ments, respectively. Iron deprivation, is a prominent feature
of the host innate immune response, and most certainly
impacts growth of Mycoplasmas in vivo [52]. Through
transcriptome analysis, MHP168_639 was identified to be
down-regulated during iron limiting conditions [52]. This
suggests that MHP168_639 may play a role in M. hyopneu-
moniae’s response to iron stress. In 168-L, MHP168L_639
has a missense mutation resulting in an E411K replace-
ment. Mutations in these metabolism-related genes accu-
mulated over 300 in vitro passages likely affect growth and
survival within host cells.
In addition, approximately 41% of mutations affected
genes coding for hypothetical proteins. Despite the lack
of functional annotations for these genes, their disrup-
tion in 168-L makes them obvious targets for investiga-
tion as potential virulence factors. Further molecular
genetics and in vivo studies are required to confirm and
assess the relative importance of these genes in the at-
tenuation of virulence in 168-L.
Conclusions
We successfully used a combination of sequencing gen-
omics and comparative genomics strategies to provide a
comprehensive analysis of virulent and attenuated M.
hyopneumoniae strains to identify determinants involved
in pathogenesis. The genome of the attenuated high-
passage derivative strain 168-L was sequenced and com-
pared to virulent strain 168, revealing mutations in
numerous CDSs. These mutations affected CDSs are
likely to be associated with virulence. We then compared
these putative virulence factor CDSs to reportedvirulence determinants. Notably, almost all of the reported
M. hyopneumoniae virulence determinants were included
in the list of putative virulence factor CDSs. Variations in
the previously described mycoplasma adhesins (P97, P102,
P146, P159, P216 and LppT), cell envelope proteins (P95),
cell surface antigens (P36), secreted proteins, chaperone
protein (DnaK), and genes directly related to metabolism
and in vivo growth may contribute to loss of virulence in
168-L. We then proceeded to characterize the alterations
in gene functions caused by mutations at the protein level,
and compared those mutations with previously described
repeat motifs that may be of primary importance for viru-
lence [34]. Interestingly, we found that many mutations
were located in the virulence associated motifs of the vari-
ous proteins. To bind cilia, a minimum of eight tandem
copies of the pentapeptide sequence (AAKPV/E) in the R1
region of P97 are required [5]. We identified three muta-
tions in the tandem repeat unit (AAKPV/E), causing an
E863V substitution. A similar situation was also observed
in several other virulence associated genes (P146, P159,
P216, and LppT). We hypothesize that the cumulative
effect of mutations in virulence associated genes may ac-
count for the attenuation of virulence in 168-L. In this
study, a total of 330 genetic variations were identified.
While these included reported virulence-related genes,
other novel virulence determinants were also identified.
However, further molecular genetics and in vivo studies
are required to confirm and assess the relative importance
of these suspected novel virulence determinants in the at-
tenuation of virulence. The comparative genomic analysis
presented here will not only provide insights into the basis
of attenuation of virulence in 168-L, but may also provide
targets for mutagenesis in the pursuit of development of a
more efficacious vaccine.
Methods
Bacterial strains, growth conditions, and DNA extraction
Clonal isolates of M. hyopneumoniae strain 168 and
168-L were selected for sequencing. Both of the strains
were grown in KM2 cell-free medium at 37°C. The cul-
ture was harvested from 100 mL KM2 cell-free medium
by centrifugation at 1,200×g for 30 min, and then total
genomic DNA was extracted from mycoplasma cultures
using a TIANamp Bacteria DNA Kit (Tiangen, Beijing,
China) according to the manufacturer’s instructions.
Genome sequencing and assembly
Genomic libraries containing 8 kb inserts were con-
structed according to the manufacturer’s protocols.
Whole-genome sequencing of strain 168-L was per-
formed by combining GS FLX and Solexa paired-end
sequencing technologies. A total of 242,507 reads (67.4%
paired ends) were produced with the GS FLX system,
giving 44.5-fold coverage of the genome. Eighty-eight
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scaffold using Newbler (454 Life Sciences, Branford, CT,
USA). A total of 1,971,358 reads were generated with an
Illumina Solexa genome analyzer IIx (Illumina, San
Diego, CA, USA) and were mapped to the scaffold with
the Burrows-Wheeler Alignment (BWA) tool [53]. Gaps
were filled by local assembly of the Solexa/Roche 454
reads or sequencing PCR products using a Prism 3730
capillary sequencer (Applied Biosystems, Foster City,
CA, USA). All repeated DNA regions and low-quality
regions were verified by PCR and sequencing of the
product amplified from genomic DNA.
Annotation and sequence analyses
Open reading frames containing more than 30 amino acid
residues were predicted using Glimmer 3.0 [54] with
modified genetic code 4 and verified manually using the
strain 168 annotation. Loci discrepancies between the 168
and 168-L consensus sequences were manually examined
for support at the trace data level. Transfer RNA (tRNA)
and ribosomal RNA (rRNA) genes were predicted using
the tRNAscan-SE program [55] or by observing similar-
ities with the M. hyopneumoniae strain 232 and strain J
rRNA genes. Artemis (release 12) [56] was used to collate
and annotate data. Functional predictions were based on
BLASTP similarity searches against the UniProtKB [57],
GenBank [58], Swiss-Prot protein [59], and COG [60]
databases. EC numbers were assigned using the Kyoto
Encyclopedia of Genes and Genomes (KEGG) [67] and
metabolic pathways were mapped and analyzed using
KEGG Pathway Database (http://www.genome.jp/kegg/
pathway.html). Pseudogenes were detected by BLASTN
analysis, comparing the genome sequences of 168-L with
those of 232 and J, and then the annotation was revised
manually.
Single nucleotide polymorphism (SNP) analysis
Nucleotide comparisons and single nucleotide poly-
morphism (SNP) analysis for strains 168 and 168-L were
performed using the Artemis Comparison Tool (ACT)
[61] and Mauve 2.3.1 genome alignment software [62].
ORF graphical visualization and manual annotation were
carried out using Artemis, release 12 [56]. Screening for
unusual coding differences between the 168 and 168-L
genomes (stops and frame shifts) was conducted using
FASTA program packages [63,64] and BLAST [65]. The
coding differences between the 168 and 168-L genomes
were checked manually.
Accession numbers
M. hyopneumoniae strains 168 and 168-L genome seq-
uences have been deposited in GenBank under accession
numbers CP002274.1 and CP003131, respectively.Additional files
Additional file 1: Table S1. Nucleotide differences identified between
genomes of 168 and 168-L.
Additional file 2:Table S2. Insertions detected in 168-L compared to
168.
Additional file 3: Table S3. Deletions detected in 168-L compared to
168.
Additional file 4: Table S4. SNVs detected in 168-L compared to 168.
Additional file 5: Table S5. Annotated CDS of the elements ICEH168
and ICEH168-L.
Additional file 6: Table S6. Complete list of "168-L-specific" genetic
variations in intergenic.
Additional file 7: Table S7. Mutations affecting genes with ABC
transporter family signatures.
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